AML Classifier for WHO 2022 and ICC 2022

Haem.io provides an explainable AML classifier for genomic-era hematology workflows. The platform is built to execute complex guideline logic consistently, with transparent evidence trails and risk outputs aligned to ELN guidance.

Current production focus is AML and MDS pathways. Teams can review deterministic outputs, compare WHO and ICC framing, and move from diagnostic reasoning to actionable classification in a single workflow.

What this page targets

Acute myeloid leukemia diagnosis support
AML classification with WHO 2022 and ICC 2022 criteria
Explainable clinical decision support in hematology

Try the interactive classifier Leukemia diagnostic tool overview Read related articles